RecruitingPhase 4NCT05929755

Depo-Medrol on Psoas After LLIF

Effect of Depo-Medrol Application on the Psoas Muscle After Transpsoas LLIF on Post-operative Hip Flexor Weakness, Thigh Pain and Numbness

Sponsor

Hardeep Singh

Enrollment

80 participants

Start Date

May 12, 2023

Study Type

INTERVENTIONAL

Conditions

Pain, Postoperative Muscle Weakness Paresthesia Pain, Muscle

Summary

The goal of this study is to determine the effects of a corticosteroid administered to the psoas muscle following a transpsoas lateral lumbar interbody fusion (LLIF) on postoperative hip flexor weakness and thigh pain and numbness.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Depo-Medrol and a drug called Gel-Flow NT for people with muscle weakness, pain, muscle, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.